Suven Formulation Development Center

Suven Formulation Development Center (FDC) is a Contract Research Organization with the state of the art facility having  110,000+ sq. ft of world-class infrastructure comprising of formulation development laboratories (6), Process development laboratories (2), Technology development laboratories (8), analytical method development & validation laboratories, stability walk-in chambers (10) to cater to the stability studies as per ICH guidelines for Zone I to Zone IV climatic conditions, cGMP Scale-up, Manufacturing and Packing of Exhibit and Clinical Supply batches and Packaging Development and Testing Laboratories.

  • Pharmaceutical Dosage Form Development for Global Markets Including Analytical & Regulatory Services
  • Equipped with State-of-the Art Infrastructure in 110,000 Sft. Facilities for Product Development, Technology Development, Analytical, cGMP Compliant Pilot / Small scale Manufacturing
  • Qualified and Experienced Team

Generic Product Development

  • Pre-Formulation Studies
  • Formulation Development
  • Process Development
  • Exhibit / Submission / Pivotal Batches
  • Co-ordination with CROs for BE Studies*
  • Technology Transfer

New Chemical Entities (NCE) Formulations

  • Product Development (Preclinical & Clinical)
  • Clinical Trials Material (CTM):
  • Multi-Product Manufacturing for Ph-I, II, III (Including Placebo)
  • Multi-Product Packaging for Ph-I, II, III

New / Novel Drug Delivery Systems

  • Modified Release
  • Technology Platforms
  • Alternate Routes of Delivery

Analytical Services

  • Analytical Method Development
  • Analytical Method Validation
  • Impurity Profiling
  • Stability Testing
  • Microbiological Testing

Regulatory Services

  • Pre & Post Submission
  • Pre & Post Approval

Parenteral Iron Formulations

First Line Treatment for Iron Deficiency Anemia in Non-Dialysis, Hemo Dialysis and Peritoneal Dialysis Dependent Patients

Iron Sucrose Injection USP
Sodium Ferric Gluconate Complex in Sucrose Injection

Niche Formulation Portfolio

Treatment of Choice for Head Lice

Malathion Lotion USP - 0.5%
* Customer exclusivity for some markets.

* All transactions are carried out in conformity with patent laws applicable in the user country